🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
Research has consistently found that cognitive impairment is common in pers...
Status
Suspended
Location
12&12, Inc
Start Date
2020-03-06
Trial ID
NCT04404348
Treatments Being Tested
The investigators will conduct a randomized, double-blinded, sham-controlle...
Status
Recruiting
Location
Johns Hopkins Bayview Medical Center
Start Date
2022-09-01
Trial ID
NCT05195398
Treatments Being Tested
The aim of the MAPEG 2 study is to explore gustatory function and to follow...
Status
Recruiting
Location
Chu Dijon Bourgogne
Start Date
2023-06-12
Trial ID
NCT05888961
This clinical trial tests the feasibility and utility of a biology guided t...
Status
Not Yet Recruiting
Location
City of Hope Medical Center
Start Date
2026-12-19
Trial ID
NCT07590583
This phase I trial studies on how the PEOX-based polymer encapsulated pacli...
Status
Terminated
Location
Los Angeles General Medical Center
Start Date
2024-04-01
Trial ID
NCT06338657
This study is examining the efficacy of a computerized, exposure-based, int...
Status
Completed
Location
Florida State University, Department of Psychology
Start Date
2022-08-30
Trial ID
NCT05351710
Treatments Being Tested
This clinical trial tests how well dynamic contrast enhanced magnetic reson...
Status
Not Yet Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2026-09-01
Trial ID
NCT07705919
This phase II clinical trial studies how well craniospinal irradiation (CSI...
Status
Recruiting
Location
University of California San Francisco
Start Date
2025-03-03
Trial ID
NCT06518057
This phase II trial tests how well nemtabrutinib in combination with pembro...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2026-08-15
Trial ID
NCT06863402